文献引用
-
1) Boost therapy of hepatocellular carcinoma by amplifying vicious cycle between mitochondrial oxidative stress and endoplasmic reticulum stress via biodegradable ultrasmall nanoparticles and old drug.
-
2) SARS-CoV-2 in the pancreas and the impaired islet function in COVID-19 patients.
-
3) Vascular Derived ECM Improves Therapeutic Index of BMP‐2 and Drives Vascularized Bone Regeneration.
-
4) pH‐Triggered Size‐Tunable Silver Nanoparticles: Targeted Aggregation for Effective Bacterial Infection Therapy.
-
5) Toxin-Enabled “On-Demand” Liposomes for Enhanced Phototherapy to Treat and Protect against Methicillin-Resistant Staphylococcus aureus Infection.
-
6) Alzheimer's-like signaling in brains of COVID-19 patients.
-
7) Cell-Free Extracts from Human Fat Tissue with a Hyaluronan-Based Hydrogel Attenuate Inflammation in a Spinal Cord Injury Model through M2 Microglia/Microphage Polarization.
-
8) IL-6-induced cGGNBP2 encodes a protein to promote cell growth and metastasis in intrahepatic cholangiocarcinoma.
-
9) Microvesicle-inspired oxygen-delivering nanosystem potentiates radiotherapy-mediated modulation of tumor stroma and antitumor immunity.
-
10) An injectable antibacterial chitosan-based cryogel with high absorbency and rapid shape recovery for noncompressible hemorrhage and wound healing.
-
11) Gold nanoparticles targeting the autophagy–lysosome system to combat the inflammation-compromised osteogenic potential of periodontal ligament stem cells: From mechanism to therapy.
-
12) A quaternized chitin derivatives, egg white protein and montmorillonite composite sponge with antibacterial and hemostatic effect for promoting wound healing.
产品: 1年份: 2022期刊: Composites Part B: Engineering影响因子: 12.700DOI: 10.1016/j.compositesb.2022.109661 -
13) Life-threatening viral disease in a novel form of autosomal recessive IFNAR2 deficiency in the Arctic.
-
14) CDK4/6 inhibition suppresses p73 phosphorylation and activates DR5 to potentiate chemotherapy and immune checkpoint blockade.
-
15) Nintedanib enhances the efficacy of PD-L1 blockade by upregulating MHC-I and PD-L1 expression in tumor cells.